Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV
Open Access
- 22 January 2008
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 98 (4) , 818-823
Abstract
The purpose of this study was to compare the diagnostic interest of Hector Battifora mesothelial antigen-1 (HBME-1), thyroid peroxidase (TPO), and dipeptidyl aminopeptidase IV (DPP4) in thyroid fine-needle aspirates obtained from 200 resected thyroid lesions (55 colloid nodules, 54 follicular adenomas, 59 papillary cancers, and 32 follicular carcinomas). Hector Battifora mesothelial antigen-1 or TPO expression (% positive cells) and DPP4 staining score (12-point scale) were evaluated. Receiver operating characteristic (ROC) curves were plotted and optimal cutoff values for diagnosing malignancy were determined. The TPO ROC curve was consistently higher than the HBME-1 ROC curve. The TPO curve was also higher than the DPP4 curve with regard to sensitivity, but dipped below the DPP4 curve with regard to specificity. Using a cutoff value of 10% positive cells for HBME-1, and staining score 1 for DPP4, sensitivity to specificity ratios were 98–83% for TPO, 90–60% for HBME-1, and 88–80% for DPP4. Two particularly interesting findings of this study were the low negative likelihood ratio of TPO (0.02) allowing highly reliable exclusion of malignancy and the 100% specificity of DPP4 staining scores=12. Due to poor performance on follicular lesions, HBME-1 showed no advantage over TPO or DPP4.Keywords
This publication has 36 references indexed in Scilit:
- Expression microarray analysis of papillary thyroid carcinoma and benign thyroid tissue: emphasis on the follicular variant and potential markers of malignancyVirchows Archiv, 2007
- Diagnostic Usefulness of HBME1, Galectin-3, CK19, and CITED1 and Evaluation of Their Expression in Encapsulated Lesions With Questionable Features of Papillary Thyroid CarcinomaAmerican Journal of Clinical Pathology, 2006
- Diagnostic Usefulness of HBME1, Galectin-3, CK19, and CITED1 and Evaluation of Their Expression in Encapsulated Lesions With Questionable Features of Papillary Thyroid CarcinomaAmerican Journal of Clinical Pathology, 2006
- Microarray Analysis of Thyroid Nodule Fine-Needle Aspirates Accurately Classifies Benign and Malignant LesionsThe Journal of Molecular Diagnostics, 2006
- Assessing the Utility of a Mutational Assay for B-RAF as an Adjunct to Conventional Fine Needle Aspiration of the Thyroid GlandAdvances in Anatomic Pathology, 2006
- Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potentialLaboratory Investigation, 2005
- Immunohistochemical Diagnosis of Papillary Thyroid CarcinomaLaboratory Investigation, 2001
- Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid noduleClinical Endocrinology, 2000
- In Situ Hybridization and Immunohistochemistry Study of Thyroid Peroxidase Expression in Thyroid TumorsThyroid®, 2000
- Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissuesCancer, 1991